Charles Schwab’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,225
Closed -$96.6K 3543
2025
Q1
$96.6K Sell
11,225
-1,280
-10% -$11K ﹤0.01% 3348
2024
Q4
$447K Hold
12,505
﹤0.01% 3172
2024
Q3
$591K Hold
12,505
﹤0.01% 3105
2024
Q2
$628K Buy
12,505
+670
+6% +$33.7K ﹤0.01% 3098
2024
Q1
$1.33M Sell
11,835
-488
-4% -$54.7K ﹤0.01% 2709
2023
Q4
$715K Buy
12,323
+547
+5% +$31.7K ﹤0.01% 2947
2023
Q3
$374K Sell
11,776
-21,052
-64% -$668K ﹤0.01% 3153
2023
Q2
$2.7M Buy
32,828
+3,641
+12% +$299K ﹤0.01% 2458
2023
Q1
$3M Buy
29,187
+2,346
+9% +$241K ﹤0.01% 2412
2022
Q4
$3.93M Buy
26,841
+1,095
+4% +$160K ﹤0.01% 2337
2022
Q3
$4.35M Sell
25,746
-501
-2% -$84.7K ﹤0.01% 2287
2022
Q2
$3.03M Buy
26,247
+7,661
+41% +$885K ﹤0.01% 2410
2022
Q1
$1.85M Sell
18,586
-934
-5% -$93.2K ﹤0.01% 2671
2021
Q4
$3.04M Buy
19,520
+228
+1% +$35.5K ﹤0.01% 2565
2021
Q3
$4.55M Buy
19,292
+2,793
+17% +$659K ﹤0.01% 2422
2021
Q2
$5.6M Buy
16,499
+1,692
+11% +$574K ﹤0.01% 2296
2021
Q1
$5.99M Buy
14,807
+477
+3% +$193K ﹤0.01% 2205
2020
Q4
$9.53M Buy
14,330
+191
+1% +$127K ﹤0.01% 1894
2020
Q3
$6.58M Buy
14,139
+9,391
+198% +$4.37M ﹤0.01% 1937
2020
Q2
$2.78M Buy
4,748
+1,304
+38% +$763K ﹤0.01% 2299
2020
Q1
$502K Buy
3,444
+42
+1% +$6.12K ﹤0.01% 2712
2019
Q4
$488K Hold
3,402
﹤0.01% 2822
2019
Q3
$135K Hold
3,402
﹤0.01% 3080
2019
Q2
$345K Buy
3,402
+2,008
+144% +$204K ﹤0.01% 2970
2019
Q1
$184K Buy
1,394
+414
+42% +$54.6K ﹤0.01% 3036
2018
Q4
$100K Sell
980
-144
-13% -$14.7K ﹤0.01% 3088
2018
Q3
$281K Buy
1,124
+144
+15% +$36K ﹤0.01% 3018
2018
Q2
$438K Buy
980
+168
+21% +$75.1K ﹤0.01% 2845
2018
Q1
$321K Buy
+812
New +$321K ﹤0.01% 2853